Unknown

Dataset Information

0

A DNA Vaccine Incorporating the MHC Class I Trafficking Domain and PADRE Epitope Enhances Antitumor Immunity in a Murine Pancreatic Cancer Model

ABSTRACT:

SUBMITTER: Cao S 

PROVIDER: S-EPMC12940583 | biostudies-literature | 2026 Feb

REPOSITORIES: biostudies-literature

Json Xml

Similar Datasets

Transcriptomics Cold-inducible brown fat thermogenesis enhances MHC class I expression and antitumor immunity in ovarian cancer.
2025-12-31 | GSE264447 | GEO
Unknown NetCTLpan: pan-specific MHC class I pathway epitope predictions.
| S-EPMC2875469 | biostudies-literature
Unknown A conjoined universal helper epitope can unveil antitumor effects of a neoantigen vaccine targeting an MHC class I-restricted neoepitope.
| S-EPMC7814002 | biostudies-literature
Unknown BET inhibition triggers antitumor immunity by enhancing MHC class I expression in head and neck squamous cell carcinoma.
| S-EPMC9637808 | biostudies-literature
Unknown Targeting cathepsin B by cycloastragenol enhances antitumor immunity of CD8 T cells via inhibiting MHC-I degradation.
| S-EPMC9621195 | biostudies-literature
Unknown Cutting Edge: Inhibition of the Interaction of NK Inhibitory Receptors with MHC Class I Augments Antiviral and Antitumor Immunity.
| S-EPMC7369225 | biostudies-literature
Unknown Combining STING-based neoantigen-targeted vaccine with checkpoint modulators enhances antitumor immunity in murine pancreatic cancer.
| S-EPMC6237485 | biostudies-literature
Unknown Neoleukin-2 enhances anti-tumour immunity downstream of peptide vaccination targeted by an anti-MHC class II VHH.
| S-EPMC7058936 | biostudies-literature
Unknown CD70 encoded by modified vaccinia virus Ankara enhances CD8 T-cell-dependent protective immunity in MHC class II-deficient mice.
| S-EPMC5980220 | biostudies-literature
Unknown BPTF Depletion Enhances T-cell-Mediated Antitumor Immunity.
| S-EPMC5093041 | biostudies-literature